首页> 外文期刊>Allergy, Asthma & Immunology Research >A Case of Pranlukast-Induced Anaphylactic Shock
【24h】

A Case of Pranlukast-Induced Anaphylactic Shock

机译:普仑司特致过敏性休克一例

获取原文
           

摘要

Leukotriene receptor antagonists, which are generally considered safe with a few adverse drug reactions, are increasingly used in the treatment of various allergic diseases, including asthma and allergic rhinitis. Although a few anaphylactic reactions to montelukast have been reported worldwide, there is still a lack of reports about severe adverse drug reactions associated with pranlukast. Here, we report a case of severe hypersensitivity reaction associated with pranlukast. A 65-year-old woman developed anaphylactic shock that presented as generalized urticaria, angioedema, collapse, and loss of consciousness after receiving pranlukast. A positive response to oral challenge and skin prick testing with pranlukast was observed in the patient. In this case, it was demonstrated that pranlukast can induce anaphylaxis, possibly mediated by the IgE-dependent pathway.
机译:白三烯受体拮抗剂通常被认为是安全的,具有一些药物不良反应,越来越多地用于治疗各种过敏性疾病,包括哮喘和过敏性鼻炎。尽管全世界已报道了对孟鲁司特的一些过敏反应,但仍缺乏有关与普鲁司特相关的严重药物不良反应的报道。在这里,我们报告与普鲁司特有关的严重超敏反应的情况。一名65岁的女性因服用普仑司特后出现过敏性休克,表现为全身性荨麻疹,血管性水肿,虚脱和失去知觉。在患者中观察到对口服挑战和普仑司特皮肤点刺试验的阳性反应。在这种情况下,已证明普仑司特可以诱导过敏反应,可能是由IgE依赖性途径介导的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号